Skip to main content
SpringerLink
Log in

An overview of diabetes research achievements during a quarter of a century in Diabetes Research Center

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

Endocrinology and Metabolism Research Institute (EMRI) is one of the biggest research institutes in Iran that was established to develop research strategies for managing endocrine and metabolic disorders such as diabetes. The aim of this study was to provide an overview of diabetes related research activities and achievements in the EMRI since its foundation.

Method

A comprehensive search was conducted in the PubMed, Scopus, and EMBASE to find out diabetes-related research studies performed in the EMRI. After data extraction, articles were categorized based on their document types, levels of evidence, diabetes types, and subject areas and were presented in various charts.

Result

After removing duplications and screening, 228 remained documents were categorized. The majority of diabetes investigations performed in the Diabetes Research Center (DRC) was on type 2 diabetes (T2D) (37%). Based on document types, most of these publications were original articles. Moreover, clinical studies constituted the greatest amount of evidence in the literature. According to the subject areas, most of the articles were on basic sciences and diabetes-related associated factors, followed by studies related to the management and prevention of diabetes.

Conclusions

As one of the most comprehensive research institute, the EMRI has developed its national and international research activities to improve diabetes management and cure through developing new treatment strategies, improving translational research, and applying new emerging technologies such as regenerative medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

Data is available on request.

References

  1. International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels: International Diabetes Federation; 2019.

  2. Hills S, Halban PA. DIAMAP: a road map for diabetes research in Europe. J Diabetes Sci Technol. 2011;5(3):794–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fonseca VA, Sue Kirkman M, Darsow T, Ratner RE. The American diabetes association diabetes research perspective. Diabetes Care. 2012;35:1380–7.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Geiss L, Engelgau M, Pogach L, Acton K, Fleming B, Roman S, Han L, Wang J, Vinicoret F. A national progress report on diabetes: successes and challenges. Diabetes Technol Ther. 2005;7:198–203.

    Article  PubMed  Google Scholar 

  5. Insel RA, Deecher DC, Brewer J. Juvenile Diabetes Research Foundation: mission, strategy, and priorities. Diabetes. 2012;61:30–5.

    Article  CAS  PubMed  Google Scholar 

  6. Nasli-Esfahani E, Peimani M, Rambod C, Omidvar M, Larijani B. Developing a clinical diabetes guideline in diabetes research network in Iran. Iran J Public Health. 2014;43:713–21.

    PubMed  PubMed Central  Google Scholar 

  7. Bandarian F, Omidvar M, Razi F, Nasli-Esfahani E, Saeedeh Saeedi, Larijani B. Iran diabetes research roadmap (IDRR) study; Knowledge gap in genetic research on diabetes mellitus in Iran: A review article. Iran J Public Health. 2017;46:53–9.

    Google Scholar 

  8. Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghasemabadi R, Khajavi A, Peimani M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017;16:9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Rambod C, Shafiee G, Bandarian F, Larijani B, Razi F. Iran diabetes research roadmap (IDRR) study; Research gap in gestational diabetes in Iran: A review article. Iran J Public Health. 2017;46:68–75.

    Google Scholar 

  10. Saeedi S, Bandarian F, Meshkani R, Nourbakhsh M, Nasli-Esfahani E, Larijani B. Iran diabetes research roadmap (IDRR) study; Trends of basic sciences publication: A review article. Iran J Public Health. 2017;46:60–7.

    Google Scholar 

  11. Shafiee G, Bandarian F, Ghodsi M, Nasli-Esfahani E, Larijani B. Iran Diabetes Research Roadmap (IDRR) study; Trends of publications in management of diabetes in Iran: A review article. Iran J Public Health. 2017;46:3–9.

    Google Scholar 

  12. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Supplement 1):14–31.

    Article  Google Scholar 

  13. Süt N. Study designs in medicine. Balkan Med J. 2014;31:273–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:2535.

    Article  Google Scholar 

  15. Akhbari M, Khalili M, Shahrabi-Farahani M, Biglari A, Bandaria F. Expression level of circulating cell free miR-155 gene in serum of patients with diabetic nephropathy. Clin Lab. 2019;65. https://doi.org/10.7754/Clin.Lab.2019.190209.

  16. Akhbari M, Shahrabi-Farahani M, Biglari A, Bandarian F, Khalili M. Expression level of circulating miR-93 in serum of patients with diabetic nephropathy. Turk J Endocrinol Metab. 2018;22:78–84.

    Article  Google Scholar 

  17. Asgarbeik S, Mohammad Amoli M, Enayati S, Bandarian F, Nasli-Esfahani E, Forouzanfar K, Razi F, Angaji SA. The role of ERRFI1 + 808T/G polymorphism in diabetic nephropathy. Int J Mol Cell Med. 2019;8:49–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Delfan M, Delphan M, Kordi MR, Ravasi AA, Safa M, Gorgani-Firuzjaee S, Fatemi A, Bandarian F, Nasli-Esfahani E. High intensity interval training improves diabetic cardiomyopathy via miR-1 dependent suppression of cardiomyocyte apoptosis in diabetic rats. J Diabetes Metab Disord. 2020;19:145–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bandarian F, Larijani B. World diabetes day: celebrating two decades of Progress in combating diabetes and its complications in Iran. J Diabetes Metab Disord. 2019;18:743–5.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Niazpour F, Bandarian F, Nasli-Esfahani E, Ebrahimi R, Abdollahi M, Razi F. The effect of blood sample storage conditions on HbA1c concentration. Clin Lab. 2019;65. https://doi.org/10.7754/Clin.Lab.2019.19011421.

  21. Razi F, Bandarian F, Niazpour F, Shafiee G, Heshmat R, Abdollahi M, Seiedzadeh M, Forouzanfar K, Homayouni M, Rambod R, Nasli-Esfahani E. Stability of thirty-four analytes in blood samples of diabetic patients. Clin Lab. 2020;66:43–9.

    Article  CAS  Google Scholar 

  22. Razi F, Nasli-Esfahani E, Bandarian F. Association of serum uric acid with nephropathy in Iranian type 2 diabetic patients. J Diabetes Metab Disord. 2018;17:71–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pirjani R, Shirzad N, Qorbani M, Phelpheli M, Nasli-Esfahani E, Bandarian F, Hemmatabadi M. Gestational diabetes mellitus its association with obesity: a prospective cohort study. Eat Weight Disord. 2017;22:445–50.

    Article  PubMed  Google Scholar 

  24. Nasli Esfahani E, Ghavamzadeh A, Larijani B. Therapeutic uses of stem cells in endocrinology - Review article. Iran J Public Health. 2014;43:35–48.

    Google Scholar 

  25. Esmaeili S, Bandarian F, Esmaeili B, Nasli-Esfahani E. Apelin and stem cells: the role played in the cardiovascular system and energy metabolism. Cell Biol Int. 2019;43:1332–45.

    Article  CAS  Google Scholar 

  26. Peimani M, Nasli-Esfahani E, Sadeghi R. Patients’ perceptions of patient-provider communication and diabetes care: A systematic review of quantitative and qualitative studies. Chronic Illn. 2020;16:3–22.

    Article  PubMed  Google Scholar 

  27. Namazi N, Larijani B, Azadbakht L. Low-carbohydrate-diet score and its association with the risk of diabetes: A systematic review and meta-analysis of cohort studies. Horm Metab Res. 2017;49:565–71.

    Article  CAS  PubMed  Google Scholar 

  28. Namazi N, Brett NR, Bellissimo N, Larijani B, Heshmati J, Azadbakht L. The association between types of seafood intake and the risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Health Promot Perspect. 2019;9:164–73.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86–9.

    Article  PubMed  Google Scholar 

  30. Nyanchoka L, Tudur-Smith C, Thu VN, Iversen V, Tricco AC, Porcher R. A scoping review describes methods used to identify, prioritize and display gaps in health research. J Clin Epidemiol. 2019;109:99–110.

    Article  PubMed  Google Scholar 

  31. Peimani M, Bandarian F, Aalaa M, Kouhnavard M, Nasli Esfahani E, Larijani B. Iran diabetes research roadmap (IDRR) study; Patient education in diabetes: A review article. Iran J Public Health. 2017;46:10–6.

    Google Scholar 

  32. Khaksar Haghani F, Naeimi S, Razi F, Rambod C, Peimani M, Larijani B. Iran diabetes research roadmap (IDRR) study; Diabetes and exercise: A review article. Iran J Public Health. 2017;46:26–31.

    Google Scholar 

  33. Abbasi R, Bitarafan F, Khodaeian M, Ebrahim-Habibi A, Abbasi F, Amoli MM. Molecular investigation of WFS1 gene exon 8 in Iranian patients with Wolfram syndrome. Int J Diabetes Dev Countries. 2016;36:75–80.

    Article  CAS  Google Scholar 

  34. Razi F, Esmaili M, Nasli-Esfahani E, Yaghmaei P, Qorbani M, Mohammadi Z, et al. Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus. Menopause. 2016;23:280–5.

    Article  PubMed  Google Scholar 

  35. Peimani M, Rambod C, Omidvar M, Larijani B, Ghodssi-Ghassemabadi R, Tootee A, Nasli Esfahani E. Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: A feasibility study. Prim Care Diabetes. 2016;10:251–8.

    Article  PubMed  Google Scholar 

  36. Razi F, Sadat Daneshpour M, Karimoei M, Mehrabzadeh M, Bandarian F, Bahreini E, et al. AGTR1 rs5186 variants in patients with type 2 diabetes mellitus and nephropathy. Meta Gene. 2018;15:50–4.

    Article  Google Scholar 

  37. Nasli-Esfahani E, Larijani B, Amini P, Ghodssi-Ghassemabadi R, Razmandeh R. Effect of treatment of iron deficiency anemia on hemoglobin A1c in type 2 diabetic patients. Turk J Med Sci. 2017;47:1441–6.

    Article  CAS  PubMed  Google Scholar 

  38. Khosravi-Maharlooei M, Hajizadeh-Saffar E, Tahamtani Y, Basiri M, Montazeri L, Khalooghi K, et al. Therapy of endocrine disease: Islet transplantation for type 1 diabetes: So close and yet so far away-review. Eur J Endocrinol. 2015;173:R165-83.

    Article  PubMed  CAS  Google Scholar 

  39. Fathollahi A, Massoud A, Amirzargar AA, Aghili B, Nasli Esfahani E, Rezaei N. sICAM-1, sVCAM-1 and sE-Selectin levels in Type 1 diabetes. Fetal Pediatr Pathol. 2018;37:69–73.

    Article  CAS  PubMed  Google Scholar 

  40. Tavakkoli Bazzaz J, Amoli MM, Taheri Z, Larijani B, Pravica V, Hutchinsonet IV. TGF-β1 and IGF-I gene variations in type 1 diabetes microangiopathic complications. J Diabetes Metab Disord. 2014;13:45.

    Article  CAS  Google Scholar 

  41. Esteghamati A, Larijani B, Haji Aghajani M, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: Prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7:13461.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Razi F, Khashayar P, Ghodssi-Ghassemabadi R, Mehrabzadeh M, Peimani M, Bandarian F, et al. Optimal glycated hemoglobin cutoff point for diagnosis of Type 2 Diabetes in Iranian Adults. Can J Diabetes. 2018;42:582–7.

    Article  PubMed  Google Scholar 

  43. Mansour A, Mohajeri-Tehrani MR, Qorbani M, Heshmat R, Larijani B, Hosseini S. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes. Nutrition. 2015;31:119–26.

    Article  CAS  PubMed  Google Scholar 

  44. Asdadollahpour E, Daneshpour M, Sedaghati Khayat B, Hashemiaghdam A, Amoli MM, Qorbani M, Razi F. Non-muscle myosin heavy chain 9 gene (MYH9) polymorphism (rs4821481) is associated with urinary albumin excretion in Iranian diabetic patients. Iran Red Crescent MedJ. 2017;19:e40076.

    Google Scholar 

  45. Larijani B, Salimi M, Pourkhalili N, Mohammadirad A, Baeeri M, Nili Ahmadabadi A, et al. Positive response of isolated rat pancreatic islets to IMOD; Hopes for better transplant outcome and graft function. Asian J Anim Vet Adv. 2011;6:1019–25.

    Article  Google Scholar 

  46. Neyazi N, Mohammadi Farsani T, Nouri Z, Ghahremani MH, Khorramizadeh MR, Tajerani R, et al. Potential efficacy of Lactobacillus casei IBRC_M10711 on expression and activity of insulin degrading enzyme but not insulin degradation. In Vitro Cell Dev Biol Anim. 2017;53:12–9.

    Article  CAS  PubMed  Google Scholar 

  47. Fakhrzadeh H, Sharifi F, Mehrdad N, Jafar Aghaei F, Badamchi Z, Nazari N. Adiponectin and markers of subclinical atherosclerosis in early type 2 diabetes: Evaluation of carotid artery intima-media thickness and coronary artery calcium score. Tehran Uni Med J. 2013;71:437–44.

    CAS  Google Scholar 

  48. Ahmadkhaniha R, Mansouri M, Yunesian M, Omidfar K, Zare Jeddi M, Larijani B, et al. Association of urinary bisphenol a concentration with type-2 diabetes mellitus. J Enviorn Health Sci Eng. 2014;12:64.

    Article  Google Scholar 

  49. Razi F, Arshadi Meshkani M, Zarrabi F, Sadr M, Asgarbeik S, Bandarian F, et al. Haplotypes in vitamin D receptor gene encode risk in diabetic nephropathy. Gene. 2019;683:149–52.

    Article  CAS  PubMed  Google Scholar 

  50. Hamidi AK, Arzaghi SM, Qorbani M, Khatami F, Ebrahimi M, Bandarian F, et al. MIF 173 G > C variation was associated with depressive disorder in type 2 diabetes in an Iranian population. Psychoneuroendocrinology. 2019;104:243–8.

    Article  CAS  PubMed  Google Scholar 

  51. Asgarbeik S, Razi F, Nasli-Esfahani E, Enayati S, Angaji SA, Arshadi Mashkani M, et al. Investigating the association of rs2346061 (CNDP1), rs7577 (CNDP2), and rs1801133 (MTHFR) variants and homocysteine level with diabetic nephropathy in an Iranian population. Gene Rep. 2019;16:100443.

    Article  Google Scholar 

  52. Farhangi MA, Dehghan P, Namazi N. Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial. Eur J Nutr. 2020;59:3009–21.

    Article  CAS  PubMed  Google Scholar 

  53. Mansoori A, Sotoudeh G, Djalali M, Eshraghian MR, Keramatipour M, Nasli-Esfahani E, et al. Effect of DHA-rich fish oil on PPARgamma target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial. J Clin Lipidol. 2015;9:770–7.

    Article  PubMed  Google Scholar 

  54. Peimani M, Monjazebi F, Ghodssi-Ghassemabadi R, Nasli-Esfahani E. A peer support intervention in improving glycemic control in patients with type 2 diabetes. Patient Educ Couns. 2018;101:460–6.

    Article  PubMed  Google Scholar 

  55. Vala M, Nasli-Esfahani E, Peimani M, Arzaghi SM, Larijani B. Iran diabetes research roadmap (IDRR) study; Mental health in diabetic patients in Iran: A review article. Iran J Public Health. 2017;46:47–52.

    Google Scholar 

  56. Maghbooli Z, Pasalar P, Keshtkar AA, Farzadfar F, Larijani B. Predictive factors of diabetic complications: A possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord. 2014;13:55.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Sobhani S, Asayesh H, Sharifi F, Djalalinia S, Baradaran HR, Arzaghi SM, et al. Prevalence of diabetic peripheral neuropathy in Iran: A systematic review and meta-analysis. J Diabetes Metab Disord. 2014;13:97.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Ghorbani S, Mahdavi R, Alipoor B, Panahi G, Nasli Esfahani E, Razi F, et al. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects. Arch Physiol Biochem. 2018;124:300–5.

    Article  CAS  PubMed  Google Scholar 

  59. Ghane Basiri M, Sotoudeh G, Djalali M, Eshraghian MR, Noorshahi N, Rafiee M, et al. Association of major dietary patterns with general and abdominal obesity in Iranian patients with type 2 diabetes mellitus. Int J Vitam Nutr Res. 2015;85:145–55.

    Article  PubMed  CAS  Google Scholar 

  60. Edalat B, Sharifi F, Badamchizadeh Z, Hossein-Nezhad A, Larijani B, Mirarefin M, Fakhrzadeh H. Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus. J Diabetes Metab Disord. 2013;12:8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Larijani B, Arjmand B, Ahmadbeigi N, Falahzadeh Kh, Soleimani M, Sayahpour FA, et al. A simple and cost-effective method for isolation and expansion of human fetal pancreas derived mesenchymal stem cells. Arch Iran Med. 2015;18:770–5.

    PubMed  Google Scholar 

  62. Mohajeri-Tehrani MR, Variji Z, Mohseni Sh, Firuz A, Annabestani Z, Zartab H, et al. Comparison of a bioimplant dressing with a wet dressing for the treatment of diabetic foot ulcers: A randomized, controlled clinical trial. Wounds. 2016;28:248–54.

    PubMed  Google Scholar 

  63. Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, et al. Evaluation of fetal cell transplantation safety in treatment of diabetes: A three-year follow-up. J Diabetes Metab Disord. 2015;14:33.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Nasli-Esfahani E, Ghadami M, Amini P, Amiri S, Ghodsi M, Rambod C, et al. Transitional meningioma after fetal liver-derived cell suspension allotransplant: A case report. Exp Clin Transplant. 2017;15:231–4.

    PubMed  Google Scholar 

  65. Beigi A, Shirzad N, Nikpour F, Nasli-Esfahani E, Emamgholipour S, Bandarian F. Association between serum adropin levels and gestational diabetes mellitus; a case-control study. Gynecol Endocrinol. 2015;31:939–41.

    Article  CAS  PubMed  Google Scholar 

  66. Afshin A, Micha R, Khatibzadeh S, Fahimi S, Shi P, Powles J, et al. The impact of dietary habits and metabolic risk factors on cardiovascular and diabetes mortality in countries of the Middle East and North Africa in 2010: A comparative risk assessment analysis. BMJ Open. 2015;5:e006385.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Asadipooya K, Graves L, Lukert BP, Kalantarhormozi MR, Assadi M, Ostovar A, et al. Osteocalcin is a predictor for diabetes mellitus in postmenopausal women and correlated with oral intake of vitamin k. Mediterr J Nutr Metab. 2015;8:231–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Shahnaz Esmaeili & Ensieh Nasli-Esfahani

  2. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Fatemeh Bandarian

  3. Metabolomic and Genomic Research Center, Endocrinology and Metabolism Translational Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Farideh Razi

  4. Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of medical Sciences, Tehran, Iran

    Hossein Adibi

  5. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Ali Jalili

  6. Cell Therapy and Regenerative Medicine research Center, Endocrinology and Metabolism Translational Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Babak Arjmand

  7. Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Camelia Rambod

  8. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Ensieh Nasli-Esfahani & Bagher Larijani

Authors
  1. Shahnaz Esmaeili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatemeh Bandarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Farideh Razi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hossein Adibi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ali Jalili
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Babak Arjmand
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Camelia Rambod
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ensieh Nasli-Esfahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FB, SE: collected data, wrote the manuscript draft and revised it and approved final manuscript.

NN, MP and MRA: collected data and performed interview and approved final manuscript.

NM: critically reviewed the manuscript and approved final manuscript.

BL: provided the study concept and critically reviewed the manuscript and approved final manuscript.

EN-E and BL: the study concept and critical review of the manuscript and approving final manuscript.

SE, HA, AJ, CR, and BA: literature review and data collection and approving final manuscript.

SE, FR and FB: writing first manuscript draft and data analysis, interpretation of findings, critical review of manuscript, approving final manuscript.

Corresponding authors

Correspondence to Ensieh Nasli-Esfahani or Bagher Larijani.

Ethics declarations

Conflicts of interest/Competing interests

The authors have no conflict of interest to declare.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esmaeili, S., Bandarian, F., Razi, F. et al. An overview of diabetes research achievements during a quarter of a century in Diabetes Research Center. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-020-00714-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40200-020-00714-x

Keywords

Search

Navigation